Elon Musk Talks ‘Tech Support’ Governance as World Leaders Champion Innovation-Driven Reforms at Dubai Summit
14.2.2025 16:57:00 CET | Business Wire | Press release
Wearing a “Tech Support”-printed T-shirt, Elon Musk virtually took to the stage on the final day of the World Governments Summit in a live discussion with H.E. Omar Sultan Al Olama, UAE Minister of State for Artificial Intelligence, Digital Economy, and Remote Work Applications, to share his vision for improving government efficiency.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250214293771/en/

Elon Musk in conversation with H.E. Omar Sultan Al Olama, UAE Minister of State for Artificial Intelligence, Digital Economy, and Remote Work Applications (Photo: Business Wire)
Musk emphasized the urgency of streamlining operations, advocating for smaller, more accountable institutions to drive efficiency and economic growth.
The World Governments Summit, held in Dubai from February 11-13, brought together global leaders and experts to address critical challenges in governance, healthcare, and trade in the 21st century.
Now in its 12th edition, the Summit unveiled a suite of insights, key results, and actionable solutions developed by top policymakers, innovators, and thought leaders from around the world.
Musk stated: “We have the rule of bureaucracy as opposed to the rule of the people” and advocated for cutting regulations and government spending to stimulate economic growth, aiming for 4-5% growth without inflation by 2026.
“The overarching goal is to lay the foundation for prosperity that will last many decades, maybe centuries,” Musk added. He stressed the importance of updating government technology, noting that many systems are outdated and inefficient, such as the manual pension system. “The U.S. government needs tech support,” he quipped.
On foreign policy, Musk stated, “America should mind its own business rather than push for regime change,” signaling a shift towards less international interference. He also stressed the need to improve basic education, pointing out the U.S.’s low ranking in the OECD.
Musk also discussed Grok 3.0, his latest AI model set to launch in 1-2 weeks, calling it “scary smart.” He added, “This might be the last time any AI is better than Grok.”
Meanwhile, Joseph Tsai, Chairman of Alibaba Group, a user and admirer of Grok, argued that the value of AI isn’t in having the smartest systems, but in their application in solving real-world problems.
He compared AI development to raising children, emphasizing that not everyone needs the “smartest child.” He predicts that more resources will shift towards practical applications, leveraging open-source tools, which democratize AI development. He added: “Companies big and small can now develop AI together and contribute to the power of AI.”
Beyond AI, both Arvind Krishna, CEO of IBM, and Sundar Pichai, CEO of Google, said they looked forward to the imminent age of quantum computing, which they believe will spearhead the world into a new era.
Pichai said: “Google’s quantum computing performed a computation in five minutes that would take the fastest supercomputer over 10 septillion years.” He compared its current state to AI in the 2010s, predicting practical applications within 5-10 years.
Pichai added that for governments: “It’s too early to regulate the technology, but I think it’s important to come to a good understanding of it and then start preparing for it.”
Technology as the enabler of the new age of healthcare and education
Public healthcare systems also require innovation and new policies, argued experts at the Summit. Addressing key challenges in healthcare, Pascal Soriot, CEO of AstraZeneca, encouraged governments to develop policies that enable early disease diagnostics, improve accessibility, and encourage population-wide adoption.
Soriot stated: “Seventy-five percent of deaths come from diseases that are preventable, yet governments only spend 3% of healthcare budgets on prevention and early diagnosis.” He added that diagnostic centers should run 24/7 to reduce costs and increase accessibility.
He highlighted AI’s role in transforming healthcare, noting that it is already enhancing early diagnostics, such as lung cancer detection from X-rays, and improving efficiency in drug development. While skepticism exists around AI's role in drug design due to limited biological data, its potential in healthcare is promising.
“We are not far away from the days when a simple blood test would enable early diagnostics of cancer at a relatively low cost,” Soriot concluded.
Public-private partnerships and innovative healthcare models could further improve accessibility and cost-efficiency, helping transform global healthcare systems.
This applies beyond just healthcare. Mike Sicilia, Executive Vice President of Oracle, stated: “At the heart of every AI strategy is a data strategy. Helping governments vectorize and aggregate the data is the first step in applied AI, particularly when tailoring it to specific citizen services.”
AI applications in education were also a major focus at the Summit. David Baszucki, CEO of Roblox, explored the potential of AI in educating young users through interactive experiences on the platform. He also emphasized the importance of balancing social connectivity and safety on digital platforms.
He added: “We are at a place where it is way beyond what we imagined. In 20 years, I’m expecting an amazing amount of learning on the platform—for instance, interacting with virtual historical characters.”
Global economic challenges and financial cooperation
In parallel discussions, Kristalina Georgieva, Managing Director of the IMF, alongside finance ministers, international officials, and economic experts, explored the challenges facing the multilateral cooperation system, including rising nationalist and geopolitical trends, climate change, and economic inequality.
Speakers highlighted the need for innovative financing mechanisms and an expanded global financial safety net to address economic crises and support developing countries.
They also underlined the role of technology in strengthening financial systems, aligning global networks to protect against economic crises, and building sustainable frameworks for debt management in vulnerable economies.
For more information, visit worldgovernmentsummit.org.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250214293771/en/

Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces Positive CHMP Opinion for Opzelura® (ruxolitinib) Cream for the Treatment of Adults with Moderate Atopic Dermatitis26.6.2026 13:30:00 CEST | Press release
If approved, Opzelura® (ruxolitinib) cream will be the first steroid-free, topical JAK treatment option in the European Union (EU) for adults with moderate atopic dermatitis (AD) for whom standard topical therapies have failedAD, the most common type of eczema which affects 230 million people globally,1 is a chronic, recurring, inflammatory and highly pruritic (itchy) skin condition that can have a significant impact on daily life2Phase 3 TRuE‑AD4 data supporting the positive CHMP opinion demonstrated that ruxolitinib cream met both co‑primary endpoints at Week 8, maintained disease control with as-needed treatment through Week 24 and was well tolerated3,4,5 Incyte (Nasdaq: INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of Opzelura® (ruxolitinib) cream for the treatment of moderate atopic dermatitis (AD) in adult patients for whom topical corticosteroids
Datroway® Recommended for Approval in the EU by CHMP as First-Line Treatment for Patients with Metastatic Triple Negative Breast Cancer Who Are Not Candidates for Immunotherapy26.6.2026 13:00:00 CEST | Press release
Recommendation based on TROPION-Breast02 phase 3 trial where Daiichi Sankyo and AstraZeneca’s Datroway showed a statistically significant and clinically meaningful improvement for the dual primary endpoints of overall survival and progression-free survival If approved, Datroway has potential to be the first TROP2 directed antibody drug conjugate for patients in EU with a demonstrated overall survival benefit as first-line treatment Datroway® (datopotamab deruxtecan) has been recommended for approval in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use
DAYBU®(trofinetide) Recommended for Approval in the European Union by CHMP26.6.2026 12:49:00 CEST | Press release
-- European Commission decision expected in the coming months-- If approved, DAYBU®would become the first treatment for neurobehavioral symptoms of Rett syndrome in the European Union Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion following a re-examination procedure, recommending the granting of a marketing authorization for DAYBU® (trofinetide) for the treatment of neurobehavioral symptoms of Rett syndrome in adults and pediatric patients aged five years and older. If granted marketing authorization by the European Commission, DAYBU® would be the first therapy approved for this indication in the European Union (EU). “The CHMP’s positive opinion for DAYBU® is an important milestone in our mission to bring this innovative therapy to the EU, where there are no therapies specifically approved for the neurobehavioral symptoms of this devastating
HTEC Showcases Lakebase Branching at Databricks’ Data & AI Summit26.6.2026 11:18:00 CEST | Press release
HTEC, the global technology and AI engineering firm headquartered in Silicon Valley, last week showcased how it used Lakebase data branching to enable faster development, safer operations, and new possibilities for data-driven organizations operating in highly regulated environments. The Solution was developed in collaboration with a leading risk and compliance technology provider who serves financial institutions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260626875859/en/ HTEC, the global technology and AI engineering firm headquartered in Silicon Valley, last week showcased how it used Lakebase data branching to enable faster development, safer operations, and new possibilities for data-driven organizations operating in highly regulated environments. Solving Critical Development Bottlenecks in Regulated Environments At the core of the collaboration was a shared challenge: how to enable modern data workflows in an envi
Stallergenes Greer Named One of Switzerland’s Best Managed Companies for 202626.6.2026 10:28:00 CEST | Press release
Stallergenes Greer, a global leader in allergy care, has been recognised for its overall business performance, company culture, and sustained growth by receiving the prestigious 2026 Switzerland’s Best Managed Companies award. The 2026 Best Managed Companies programme award winners are among Switzerland’s best private companies. The awards are derived from Deloitte’s global Best Managed Companies awards programme, an internationally recognised programme that evaluates businesses based on their leadership in the areas of strategy, culture and commitment, capabilities, innovation, governance and financial performance. Applicants are evaluated by an independent jury of experts. The evaluation of the Switzerland awards is based on more than 30 years of observed practice from the global awards programme that has been rolled out in 50+ countries worldwide. This recognition reflects Stallergenes Greer's consistent ability to deliver on its strategic vision while maintaining the operational di
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom